EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo

Julia E Edgar, Stephanie Trezise iD, Robert M Anthony iD, Florian Krammer, Peter Palese, Jeffrey V Ravetch iD, Stylianos Bournazos

Proceedings of the National Academy of Sciences · 31.10.2023 · 120 (44)

DOI: 10.1073/pnas.2314905120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.10.2023. Verfasst von Julia E Edgar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065. Hauptthemen laut MEDLINE: Influenza Vaccines, Orthomyxoviridae, Influenza, Human, Orthomyxoviridae Infections. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody responses against highly conserved epitopes on the stalk domain of influenza virus hemagglutinin (HA) confer broad protection; however, such responses are limited. To effectively induce stalk-specific immunity against conserved HA epitopes, sequential immunization strategies have been developed based on chimeric HA (cHA) constructs featuring different head domains but the same stalk regions. Immunogenicity studies in small animal models, as well as in humans, revealed that cHA immunogens elicit stalk-specific IgG responses with broad specificity against heterologous influenza virus strains. However, the mechanisms by which these antibodies confer in vivo protection and the contribution of their Fc effector function remain unclear. To characterize the role of Fc-FcγR (Fcγ receptor) interactions to the in vivo protective activity of IgG antibodies elicited in participants in a phase I trial of a cHA vaccine candidate, we performed passive transfer studies of vaccine-elicited IgG antibodies in mice humanized for all classes of FcγRs, as well as in mice deficient for FcγRs. IgG antibodies elicited upon cHA vaccination completely protected FcγR humanized mice against lethal influenza virus challenge, while no protection was evident in FcγR-deficient mice, suggesting a major role for FcγR pathways in the protective function of vaccine-elicited IgG antibodies. These findings have important implications for influenza vaccine development, guiding the design of vaccination approaches with the capacity to elicit IgG responses with optimal Fc effector function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesOrthomyxoviridaeInfluenza, HumanOrthomyxoviridae InfectionsHumansAnimalsMiceHemagglutininsReceptors, IgGAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusVaccinationImmunoglobulin GEpitopes

Stichwörter der Autor:innen

Fc receptorsIgG antibodieshemagglutinininfluenza virusvaccine

Substanzen

HemagglutininsReceptors, IgGAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesImmunoglobulin GEpitopes

Autor:innen und Institutionen

  • Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065.
  • Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Center for Vaccine Research and Pandemic Preparedness, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
  • Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029.

ORCID-Profile: Stephanie Trezise, Robert M Anthony, Jeffrey V Ravetch

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Edgar, J. E., Trezise, S., Anthony, R. M., Krammer, F., Palese, P., Ravetch, J. V., & Bournazos, S. (2023). Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo. Proceedings of the National Academy of Sciences, 120(44). https://doi.org/10.1073/pnas.2314905120

Vancouver

Edgar JE, Trezise S, Anthony RM, Krammer F, Palese P, Ravetch JV, et al. Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo. Proceedings of the National Academy of Sciences. 2023;120(44). doi:10.1073/pnas.2314905120

BibTeX
@article{Edgar2023,
  author = {Edgar, Julia E and Trezise, Stephanie and Anthony, Robert M and Krammer, Florian and Palese, Peter and Ravetch, Jeffrey V and Bournazos, Stylianos},
  title = {Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcγR-dependent protection in vivo},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  volume = {120},
  number = {44},
  doi = {10.1073/pnas.2314905120}
}
Kostenlos starten →